期刊文献+

人膀胱移行细胞癌细胞株BLZ-211的生物学特性 被引量:1

HE BIOLOGICAL CHARACTERISTICS OF A NEWLY ESTABLISHED HUMAN BLADDER TRANSITIONAL CELL CARCINOMA CELL LINE(BLZ-211)
下载PDF
导出
摘要 以膀胱移行细胞癌患者的肿瘤标本为材料建立了1株克隆性膀胱癌细胞株BLZ-211,体外培养3年多,传代150次,没有支原体污染。生物学特性鉴定:光镜和超微结构显示该细胞具有膀胱移行细胞癌细胞特征。细胞接种裸鼠形成的移植肿瘤与手术标本病理形态一致。染色体众数63,有特异性的LDH同功酶谱,有p16基因的正常扩增条带。结果提示BLZ-211细胞株是一个研究人膀胱移行细胞癌细胞生物学的实用模型。 A clonal cell line (BLZ-211 ) was derived from a human bladder transitional cell carcinoma. The cells have been grown in culture for over 3years with 150 passages and are free of mycoplasmacontamination. Biological Characterizations of thecell line were performed. Morphologically, the lightand electron microscopic structure of the cells resembled that of original bladder carcinoma cells. After being implanted into nude mice, the cells couldgrown and form tumors. There was a stem linechromosome number of 63 and a distinct lactic aciddehydrogenase isozyme pattern. p16 gene was amplified in BLZ-211. The results indicate that BLZ211 cell line is different from other correspondingcell lines reported so far in literature.
出处 《西安医科大学学报》 CSCD 1999年第1期37-40,110,共5页 Journal of Xi'an Medical University(Chinese)
关键词 细胞株 BLZ-211 膀胱肿瘤 移行细胞癌 bladder carcinomal cell lined chromosome nude mice
  • 相关文献

参考文献8

二级参考文献6

  • 1何大澄,细胞生物学杂志,1984年,6卷,4期,153页
  • 2Chen T R,Exp Cell Res,1977年,104卷,255页
  • 3路桂荣,中国科学.B,1991年,1期,67页
  • 4叶昕,中国科学.B,1991年,2期,174页
  • 5俞莉章,Scanand J Urol Nephorl,1994年,157卷,Suppl期,13页
  • 6马爱红,中华泌尿外科杂志,1990年,11卷,195页

共引文献70

同被引文献8

  • 1Parker SL,Tong T,Bolden S,et al.Cancer statistics 1997[J].CA Cancer J Clin,1997,47(1):5.
  • 2Tanagho E A,Mc Aninch J W.Smith's General Urology[M].15th ed.McGraw-Hill Companies,2001:355.
  • 3Lin J,Dinney CP,Grossman HB,et al.E-cadherin promoter polymorphism(C-160A)and risk of recurrence in patients with superficial bladder cancer[J].Clin Gent,2006,70(3):240.
  • 4Miyaaga N,Akaza H,Ishikawa S,et al.Clinical evaluation of nuclear matrix protein-22(NMP-22)in urine as a novel marker for urothelial cancer[J].Eur Urol,1997,31:163.
  • 5Lokeshwer VB,Soloway MS.Current bladder tumor tests does their projected utility fulfill Clinical necessity[J].J Urol,2001,165(4):1 067.
  • 6Lokeshwer VB,Obek C,Pham HT,et al.Urinary hyaluronic acid and hyaluronidase:markers for monitoring bladder cancer detection and evaluation of grade[J].J Urol,2000,163(1):348
  • 7Eissa S,Kassim S,El-Ahmady 0.Detection of bladder tumors role of cytology,morphtology-based assays,biochemical and molecular markers[J].Curr Opin Obstet Gynecol,2003,15(5):395.
  • 8Von der Maase H,Sengelov L,Roberts J T,et al.Longterm survival results of a randomized trial comparing gencitabline plus cisplatin,with methotrexate,vinblastine,doxombicin,plus cisplatin in patients with bladder cancer[J].J Clin Oncol,2005,23(21):4 602.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部